| Product Code: ETC8633588 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Prophylactic Vaccines Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Nigeria Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Nigeria Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Nigeria Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Nigeria Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Nigeria Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Nigeria Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Nigeria Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives to improve vaccination coverage |
4.2.2 Growing awareness about the importance of preventive healthcare |
4.2.3 Rising prevalence of infectious diseases in Nigeria |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High costs associated with vaccination programs |
4.3.3 Lack of proper cold chain infrastructure for vaccine storage and distribution |
5 Nigeria Prophylactic Vaccines Market Trends |
6 Nigeria Prophylactic Vaccines Market, By Types |
6.1 Nigeria Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Nigeria Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Nigeria Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Nigeria Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Nigeria Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Nigeria Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Nigeria Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Nigeria Prophylactic Vaccines Market Export to Major Countries |
7.2 Nigeria Prophylactic Vaccines Market Imports from Major Countries |
8 Nigeria Prophylactic Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate among children under 5 years old |
8.2 Number of vaccination campaigns conducted annually |
8.3 Percentage of healthcare facilities equipped with proper cold chain storage facilities |
8.4 Vaccine wastage rate due to improper storage or handling |
8.5 Number of reported cases of vaccine-preventable diseases |
9 Nigeria Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Nigeria Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Nigeria Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Nigeria Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Nigeria Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Nigeria Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Nigeria Prophylactic Vaccines Market - Competitive Landscape |
10.1 Nigeria Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here